5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression L Pezawas, A Meyer-Lindenberg, EM Drabant, BA Verchinski, KE Munoz, ... Nature neuroscience 8 (6), 828-834, 2005 | 2490 | 2005 |
Neural mechanisms of genetic risk for impulsivity and violence in humans A Meyer-Lindenberg, JW Buckholtz, B Kolachana, A R. Hariri, L Pezawas, ... Proceedings of the National Academy of Sciences 103 (16), 6269-6274, 2006 | 1070 | 2006 |
The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology L Pezawas, BA Verchinski, VS Mattay, JH Callicott, BS Kolachana, ... Journal of Neuroscience 24 (45), 10099-10102, 2004 | 1064 | 2004 |
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia JH Callicott, RE Straub, L Pezawas, MF Egan, VS Mattay, AR Hariri, ... Proceedings of the National Academy of Sciences 102 (24), 8627-8632, 2005 | 627 | 2005 |
Prevalence and burden of bipolar disorders in European countries S Pini, V De Queiroz, D Pagnin, L Pezawas, J Angst, GB Cassano, ... European Neuropsychopharmacology 15 (4), 425-434, 2005 | 525 | 2005 |
The suppressive influence of SMA on M1 in motor imagery revealed by fMRI and dynamic causal modeling CH Kasess, C Windischberger, R Cunnington, R Lanzenberger, ... Neuroimage 40 (2), 828-837, 2008 | 323 | 2008 |
Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability AL Goldman, L Pezawas, VS Mattay, B Fischl, BA Verchinski, Q Chen, ... Archives of general psychiatry 66 (5), 467-477, 2009 | 311 | 2009 |
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression L Pezawas, A Meyer-Lindenberg, AL Goldman, BA Verchinski, G Chen, ... Molecular psychiatry 13 (7), 709-716, 2008 | 296 | 2008 |
Buprenorphine versus methadone maintenance for the treatment of opioid dependence G Fischer, W Gombas, H Eder, R Jagsch, A Peternell, G Stuhlinger, ... Addiction 94 (9), 1337-1347, 1999 | 260 | 1999 |
Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings RA Honea, A Meyer-Lindenberg, KB Hobbs, L Pezawas, VS Mattay, ... Biological psychiatry 63 (5), 465-474, 2008 | 228 | 2008 |
Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study AL Goldman, L Pezawas, VS Mattay, B Fischl, BA Verchinski, B Zoltick, ... Biological psychiatry 63 (5), 475-483, 2008 | 179 | 2008 |
Encyclopedia of psychopharmacology I Stolerman Springer Science & Business Media, 2010 | 155 | 2010 |
Functional pain syndromes: presentation and pathophysiology EA Mayer, MC Bushnell Lippincott Williams & Wilkins, 2015 | 147 | 2015 |
Impact of interacting functional variants in COMT on regional gray matter volume in human brain R Honea, BA Verchinski, L Pezawas, BS Kolachana, JH Callicott, ... Neuroimage 45 (1), 44-51, 2009 | 145 | 2009 |
fMRI measurements of amygdala activation are confounded by stimulus correlated signal fluctuation in nearby veins draining distant brain regions RN Boubela, K Kalcher, W Huf, EM Seidel, B Derntl, L Pezawas, C Našel, ... Scientific reports 5 (1), 10499, 2015 | 141 | 2015 |
Allelic variation in RGS4 impacts functional and structural connectivity in the human brain JW Buckholtz, A Meyer-Lindenberg, RA Honea, RE Straub, L Pezawas, ... Journal of Neuroscience 27 (7), 1584-1593, 2007 | 137 | 2007 |
Reduced default mode network suppression during a working memory task in remitted major depression L Bartova, BM Meyer, K Diers, U Rabl, C Scharinger, A Popovic, G Pail, ... Journal of psychiatric research 64, 9-18, 2015 | 134 | 2015 |
Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders C Spindelegger, R Lanzenberger, W Wadsak, LK Mien, P Stein, ... Molecular psychiatry 14 (11), 1040-1050, 2009 | 134 | 2009 |
Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder—implications for psychopharmacology S Kasper, J Tauscher, M Willeit, M Stamenkovic, A Neumeister, B Küfferle, ... The World Journal of Biological Psychiatry 3 (3), 133-146, 2002 | 124 | 2002 |
Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy D Winkler, E Pjrek, N Praschak-Rieder, M Willeit, L Pezawas, ... Biological Psychiatry 58 (4), 331-336, 2005 | 114 | 2005 |